The New Stack CMS Built While You Weren't Looking

Key Takeaways

• ACCESS model approves 150+ organizations for direct Medicare payments
• Ventura-backed firms like Noom and WHOOP join Medicare ecosystem
• MAHA ELEVATE offers up to $3.3M grants for lifestyle trials
• New CMS models stack to create System B+ prevention layer
• Private payers covering 165M lives align with ACCESS payments

Pulse Analysis

CMS’s recent publication of the ACCESS participant list marks a watershed moment for Medicare’s payment landscape. By authorizing more than 150 entities—including consumer‑facing brands, venture‑backed startups, and established ACO platforms—to receive direct reimbursement for outcome‑based chronic disease management, the agency is effectively birthing a new market layer. This shift moves payment responsibility from traditional fee‑for‑service encounters to measurable health outcomes, aligning incentives across the entire care continuum and encouraging rapid adoption of digital health tools, nutrition programs, and behavioral interventions.

The broader stack of CMS initiatives—TEMPO’s regulatory pathway for digital devices, MAHA ELEVATE’s $100 million grant program, and the forthcoming LEAD ACO model—creates a synergistic ecosystem dubbed “System B+.” Each model addresses a distinct segment of the prevention economy, from real‑world evidence collection to multi‑payer alignment, and together they form a cohesive infrastructure that could channel billions of dollars into preventive care. Private insurers, already covering 165 million lives, are pledging to sync their payment models with ACCESS, amplifying the financial impact and accelerating industry-wide adoption of lifestyle‑centric health solutions.

For stakeholders—health systems, digital health innovators, food and CPG companies, and investors—the implications are profound. The emerging architecture promises new revenue streams, faster market entry for technology‑enabled interventions, and a data‑rich environment for evaluating efficacy. Companies that can navigate and integrate across these overlapping models will likely secure competitive advantage, while those that remain entrenched in legacy fee‑for‑service structures risk obsolescence. As CMS continues to layer these programs, the chronic disease curve may finally bend toward prevention, reshaping the U.S. health economy for the next decade.